Business
McKesson and CD&R Agree to Take Option Care Health Private in a $5.8 Billion Home Infusion Deal
The drug distributor will own 49 per cent and the buyout firm 51 per cent of the biggest independent home infusion provider, with a route for McKesson to take the rest later. Shares jumped a third.
Oct 7, 2026
